Citations (173)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (16)
Jose G Monzon & Janet Dancey. (2012) Targeted agents for the treatment of metastatic melanoma. OncoTargets and Therapy 5, pages 31-46.
Read now
Read now
Mei-Ying Han, Hidetaka Kosako, Toshiki Watanabe & Seisuke Hattori. (2007) Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Regulates Actin Organization and Cell Motility by Phosphorylating the Actin Cross-Linking Protein EPLIN. Molecular and Cellular Biology 27:23, pages 8190-8204.
Read now
Read now
Phelps J Lambert, Aniqa Z Shahrier, Audy G Whitman, Ossie F Dyson, Adrian J Reber, James A McCubrey & Shaw M Akula. (2007) Targeting the PI3K and MAPK pathways to treat Kaposi’s sarcoma-associated herpes virus infection and pathogenesis. Expert Opinion on Therapeutic Targets 11:5, pages 589-599.
Read now
Read now
Isabelle Hmitou, Sabine Druillennec, Agathe Valluet, Carole Peyssonnaux & Alain Eychène. (2007) Differential Regulation of B-Raf Isoforms by Phosphorylation and AutoinhibitoryMechanisms. Molecular and Cellular Biology 27:1, pages 31-43.
Read now
Read now
Guadalupe Camarero, Oleg Yu Tyrsin, Chaomei Xiang, Verena Pfeiffer, Sandra Pleiser, Stefan Wiese, Rudolf Götz & Ulf R. Rapp. (2006) Cortical Migration Defects in Mice Expressing A-RAF from the B-RAF Locus. Molecular and Cellular Biology 26:19, pages 7103-7115.
Read now
Read now
Catrin A. Pritchard, Louise Hayes, Leszek Wojnowski, Andreas Zimmer, Richard M. Marais & Jim C. Norman. (2004) B-Raf Acts via the ROCKII/LIMK/Cofilin Pathway To Maintain Actin Stress Fibers in Fibroblasts. Molecular and Cellular Biology 24:13, pages 5937-5952.
Read now
Read now
Pablo Rodriguez-Viciana, Celine Sabatier & Frank McCormick. (2004) Signaling Specificity by Ras Family GTPases Is Determined by the Full Spectrum of Effectors They Regulate. Molecular and Cellular Biology 24:11, pages 4943-4954.
Read now
Read now
Paul Shapiro. (2002) Ras-MAP Kinase Signaling Pathways and Control of Cell Proliferation: Relevance to Cancer Therapy. Critical Reviews in Clinical Laboratory Sciences 39:4-5, pages 285-330.
Read now
Read now
Douglas Woods, Holly Cherwinski, Eleni Venetsanakos, Arun Bhat, Stephan Gysin, Martine Humbert, Paul F. Bray, Vicki L. Saylor & Martin McMahon. (2001) Induction of β3-Integrin Gene Expression by Sustained Activation of the Ras-Regulated Raf–MEK–Extracellular Signal-Regulated Kinase Signaling Pathway. Molecular and Cellular Biology 21:9, pages 3192-3205.
Read now
Read now
Peter Erhardt, Erin J. Schremser & Geoffrey M. Cooper. (1999) B-Raf Inhibits Programmed Cell Death Downstream of Cytochrome c Release from Mitochondria by Activating the MEK/Erk Pathway. Molecular and Cellular Biology 19:8, pages 5308-5315.
Read now
Read now
Natasha Aziz, Holly Cherwinski & Martin McMahon. (1999) Complementation of Defective Colony-Stimulating Factor 1 Receptor Signaling and Mitogenesis by Raf and v-Src. Molecular and Cellular Biology 19:2, pages 1101-1115.
Read now
Read now
Sheng Wang, Richik N. Ghosh & Srikumar P. Chellappan. (1998) Raf-1 Physically Interacts with Rb and Regulates Its Function: a Link between Mitogenic Signaling and Cell Cycle Regulation. Molecular and Cellular Biology 18:12, pages 7487-7498.
Read now
Read now
Jongkyeong Chung, Eriko Uchida, Timothy C. Grammer & John Blenis. (1997) STAT3 Serine Phosphorylation by ERK-Dependent and -Independent Pathways Negatively Modulates Its Tyrosine Phosphorylation. Molecular and Cellular Biology 17:11, pages 6508-6516.
Read now
Read now
Douglas Woods, David Parry, Holly Cherwinski, Elizabeth Bosch, Emma Lees & Martin McMahon. (1997) Raf-Induced Proliferation or Cell Cycle Arrest Is Determined by the Level of Raf Activity with Arrest Mediated by p21Cip1. Molecular and Cellular Biology 17:9, pages 5598-5611.
Read now
Read now
Andreas Sewing, Bryony Wiseman, Alison C. Lloyd & Hartmut Land. (1997) High-Intensity Raf Signal Causes Cell Cycle Arrest Mediated by p21Cip1. Molecular and Cellular Biology 17:9, pages 5588-5597.
Read now
Read now
Eugen Kerkhoff & Ulf R. Rapp. (1997) Induction of Cell Proliferation in Quiescent NIH 3T3 Cells by Oncogenic c-Raf-1. Molecular and Cellular Biology 17:5, pages 2576-2586.
Read now
Read now
Articles from other publishers (157)
Stephen C. Parnell, Archana Raman, Yan Zhang, Emily A. Daniel, Yuqiao Dai, Aditi Khanna, Gail A. Reif, Jay L. Vivian, Timothy A. Fields & Darren P. Wallace. (2022) Expression of active B-Raf proto-oncogene in kidney collecting ducts induces cyst formation in normal mice and accelerates cyst growth in mice with polycystic kidney disease. Kidney International 102:5, pages 1103-1114.
Crossref
Crossref
Islam H. Ali, Heba T. Abdel-Mohsen, Marwa M. Mounier, Mahmoud T. Abo-elfadl, Ahmed M. El Kerdawy & Iman A.Y. Ghannam. (2022) Design, synthesis and anticancer activity of novel 2-arylbenzimidazole/2-thiopyrimidines and 2-thioquinazolin-4(3H)-ones conjugates as targeted RAF and VEGFR-2 kinases inhibitors. Bioorganic Chemistry 126, pages 105883.
Crossref
Crossref
Harunori Yoshikawa, Kohei Nishino & Hidetaka Kosako. (2022) Identification and validation of new ERK substrates by phosphoproteomic technologies including Phos-tag SDS-PAGE. Journal of Proteomics 258, pages 104543.
Crossref
Crossref
Appaji Rayi, Iyad Alnahhas, Shirley Ong, Pierre Giglio & Vinay K. Puduvalli. (2021) Targeted Therapy for BRAF Mutant Brain Tumors. Current Treatment Options in Oncology 22:11.
Crossref
Crossref
Niko HenselFederica Cieri, Pamela Santonicola, Ines Tapken, Tobias SchüningMichela TaianaElisa Pagliari, Antonia JosephSilke FischerNatascha HeidrichHella BrinkmannSabrina KubinskiAnke K. BergmannManuela F. Richter, Klaus JungStefania CortiElia Di Schiavi & Peter Claus. (2021) Impairment of the neurotrophic signaling hub B-Raf contributes to motoneuron degeneration in spinal muscular atrophy. Proceedings of the National Academy of Sciences 118:18.
Crossref
Crossref
Marta Montes, Michal Lubas, Frederic S. Arendrup, Bettina Mentz, Neha Rohatgi, Sarunas Tumas, Lea M. Harder, Anders J. Skanderup, Jens S. Andersen & Anders H. Lund. (2021) The long non-coding RNA MIR31HG regulates the senescence associated secretory phenotype. Nature Communications 12:1.
Crossref
Crossref
Paul M. Epstein, Chaitali Basole & Stefan Brocke. (2021) The Role of PDE8 in T Cell Recruitment and Function in Inflammation. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Siddhesh Aras, Neeraja Purandare & Lawrence I. Grossman. 2021. Mitochondrial Metabolism. Mitochondrial Metabolism
119
163
.
Diep Nguyen, Linda Yingqi Lin, Jeffrey O. Zhou, Emily Kibby, Twan W. Sia, Tiara D. Tillis, Narine Vapuryan, Ming-Ray Xu, Rajiv Potluri, YongJoon Shin, Elizabeth A. Erler, Naomi Bronkema, Daniel J. Boehlmer, Christopher D. Chung, Caroline Burkhard, Shirley H. Zeng, Michael Grasso, Lucila A. Acevedo, Ronen Marmorstein & Daniela Fera. (2020) Identification and Characterization of a B-Raf Kinase α-Helix Critical for the Activity of MEK Kinase in MAPK Signaling. Biochemistry 59:50, pages 4755-4765.
Crossref
Crossref
Rodrigo Moisés de Almeida Leite, Isabela Demarchi & Taís Rondello Bonatti. (2020) Regorafenib – Five Years in Review. European Oncology & Haematology 16:1, pages 24.
Crossref
Crossref
Charles Ducker, Leo Kam Yuen Chow, Janice Saxton, Jürgen Handwerger, Alexander McGregor, Thomas Strahl, Robert Layfield & Peter E Shaw. (2019) De-ubiquitination of ELK-1 by USP17 potentiates mitogenic gene expression and cell proliferation. Nucleic Acids Research 47:9, pages 4495-4508.
Crossref
Crossref
Samuel Pontes-Quero, Macarena Fernández-Chacón, Wen Luo, Federica Francesca Lunella, Verónica Casquero-Garcia, Irene Garcia-Gonzalez, Ana Hermoso, Susana F. Rocha, Mayank Bansal & Rui Benedito. (2019) High mitogenic stimulation arrests angiogenesis. Nature Communications 10:1.
Crossref
Crossref
Martin Köhler, Sophia Ehrenfeld, Sebastian Halbach, Manuel Lauinger, Ulrike Burk, Nadine Reischmann, Shuofei Cheng, Corinna Spohr, Franziska Maria Uhl, Natalie Köhler, Kathrin Ringwald, Sandra Braun, Christoph Peters, Robert Zeiser, Thomas Reinheckel & Tilman Brummer. (2019) B-Raf deficiency impairs tumor initiation and progression in a murine breast cancer model. Oncogene 38:8, pages 1324-1339.
Crossref
Crossref
Fiona Hey, Catherine Andreadi, Catherine Noble, Bipin Patel, Hong Jin, Tamihiro Kamata, Kees Straatman, Jinli Luo, Kathryn Balmanno, David T.W. Jones, V. Peter Collins, Simon J. Cook, Christopher J. Caunt & Catrin Pritchard. (2018) Over-expressed, N-terminally truncated BRAF is detected in the nucleus of cells with nuclear phosphorylated MEK and ERK. Heliyon 4:12, pages e01065.
Crossref
Crossref
Timothy Travers, Cesar A. López, Que N. Van, Chris Neale, Marco Tonelli, Andrew G. Stephen & S. Gnanakaran. (2018) Molecular recognition of RAS/RAF complex at the membrane: Role of RAF cysteine-rich domain. Scientific Reports 8:1.
Crossref
Crossref
Chaitali P. Basole, Rebecca K. Nguyen, Katie Lamothe, Amanda Vang, Robert Clark, George S. Baillie, Paul M. Epstein & Stefan Brocke. (2017) PDE8 controls CD4+ T cell motility through the PDE8A-Raf-1 kinase signaling complex. Cellular Signalling 40, pages 62-72.
Crossref
Crossref
Hidetaka Kosako & Kou Motani. 2017. ERK Signaling. ERK Signaling
137
149
.
J Rauch, D Vandamme, B Mack, B McCann, N Volinsky, A Blanco, O Gires & W Kolch. (2016) Differential localization of A-Raf regulates MST2-mediated apoptosis during epithelial differentiation. Cell Death & Differentiation 23:8, pages 1283-1295.
Crossref
Crossref
Andreas WickiMario MandalàDaniela MassiDaniela TavernaHuifang TangBrian A. HemmingsGongda Xue. (2016) Acquired Resistance to Clinical Cancer Therapy: A Twist in Physiological Signaling. Physiological Reviews 96:3, pages 805-829.
Crossref
Crossref
Pawan Puri, Lynda Little-Ihrig, Uma Chandran, Nathan C. Law, Mary Hunzicker-Dunn & Anthony J. Zeleznik. (2016) Protein Kinase A: A Master Kinase of Granulosa Cell Differentiation. Scientific Reports 6:1.
Crossref
Crossref
Martin Köhler, Michael Röring, Björn Schorch, Katharina Heilmann, Natalie Stickel, Gina J Fiala, Lisa C Schmitt, Sandra Braun, Sophia Ehrenfeld, Franziska M Uhl, Thorsten Kaltenbacher, Florian Weinberg, Sebastian Herzog, Robert Zeiser, Wolfgang W Schamel, Hassan Jumaa & Tilman Brummer. (2015)
Activation loop phosphorylation regulates B‐Raf
in vivo
and transformation by
B‐Raf
mutants
. The EMBO Journal 35:2, pages 143-161.
Crossref
Crossref
Ahmed A. Samatar & Poulikos I. Poulikakos. (2014) Targeting RAS–ERK signalling in cancer: promises and challenges. Nature Reviews Drug Discovery 13:12, pages 928-942.
Crossref
Crossref
Mohammed I. El-Gamal, Mohammad Ashrafuddin Khan, Mohammed S. Abdel-Maksoud, Mahmoud M. Gamal El-Din & Chang-Hyun Oh. (2014) A new series of diarylamides possessing quinoline nucleus: Synthesis, in vitro anticancer activities, and kinase inhibitory effect. European Journal of Medicinal Chemistry 87, pages 484-492.
Crossref
Crossref
Laleh Ehsani, Cynthia Cohen, Kevin E. Fisher & Momin T. Siddiqui. (2014) BRAF Mutations in Metastatic Malignant Melanoma. Applied Immunohistochemistry & Molecular Morphology 22:9, pages 648-651.
Crossref
Crossref
Jong-In Park. (2014) Growth arrest signaling of the Raf/MEK/ERK pathway in cancer. Frontiers in Biology 9:2, pages 95-103.
Crossref
Crossref
C Chang-Yew Leow, S Gerondakis & A Spencer. (2013) MEK inhibitors as a chemotherapeutic intervention in multiple myeloma. Blood Cancer Journal 3:3, pages e105-e105.
Crossref
Crossref
Joshua R Bradish, Rodolfo Montironi, Antonio Lopez-Beltran, Kristin M Post, Gregory T MacLennan & Liang Cheng. (2013)
Towards personalized therapy for patients with malignant melanoma: molecular insights into the biology of
BRAF
mutations
. Future Oncology 9:2, pages 245-253.
Crossref
Crossref
Alyson K. Freeman, Daniel A. Ritt & Deborah K. Morrison. (2013) Effects of Raf Dimerization and Its Inhibition on Normal and Disease-Associated Raf Signaling. Molecular Cell 49:4, pages 751-758.
Crossref
Crossref
Paolo A Ascierto, John M Kirkwood, Jean-Jacques Grob, Ester Simeone, Antonio M Grimaldi, Michele Maio, Giuseppe Palmieri, Alessandro Testori, Francesco M Marincola & Nicola Mozzillo. (2012) The role of BRAF V600 mutation in melanoma. Journal of Translational Medicine 10:1.
Crossref
Crossref
Takeshi Haneda, Yuta Ishii, Hiromichi Shimizu, Keiko Ohshima, Naoyuki Iida, Hirofumi Danbara & Nobuhiko Okada. (2012) Salmonella type III effector SpvC, a phosphothreonine lyase, contributes to reduction in inflammatory response during intestinal phase of infection. Cellular Microbiology 14:4, pages 485-499.
Crossref
Crossref
Christopher J. CauntCraig A. McArdle. (2012) ERK phosphorylation and nuclear accumulation: insights from single-cell imaging. Biochemical Society Transactions 40:1, pages 224-229.
Crossref
Crossref
Catherine AndreadiCatherine NobleBipin PatelHong JinMaria M. Aguilar HernandezKathryn BalmannoSimon J. CookCatrin Pritchard. (2012) Regulation of MEK/ERK pathway output by subcellular localization of B-Raf. Biochemical Society Transactions 40:1, pages 67-72.
Crossref
Crossref
Savithri Ramurthy, Abran Costales, Johanna M. Jansen, Barry Levine, Paul A. Renhowe, Cynthia M. Shafer & Sharadha Subramanian. (2012) Design and synthesis of 6,6-fused heterocyclic amides as raf kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 22:4, pages 1678-1681.
Crossref
Crossref
Xiangqian Kong, Jie Qin, Zeng Li, Adina Vultur, Linjiang Tong, Enguang Feng, Geena Rajan, Shien Liu, Junyan Lu, Zhongjie Liang, Mingyue Zheng, Weiliang Zhu, Hualiang Jiang, Meenhard Herlyn, Hong Liu, Ronen Marmorstein & Cheng Luo. (2012) Development of a novel class of B-RafV600E-selective inhibitors through virtual screening and hierarchical hit optimization. Organic & Biomolecular Chemistry 10:36, pages 7402.
Crossref
Crossref
Alessia E. Russo, Ylenia Bevelacqua, Andrea Marconi, Andrea Veronesi & Massimo Libra. 2012. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma
265
279
.
Ricarda Herr, Franziska U Wöhrle, Christina Danke, Christian Berens & Tilman Brummer. (2011) A novel MCF-10A line allowing conditional oncogene expression in 3D culture. Cell Communication and Signaling 9:1.
Crossref
Crossref
Keith T. Flaherty. (2011) BRAF Inhibitors and Melanoma. The Cancer Journal 17:6, pages 505-511.
Crossref
Crossref
G Maurer, B Tarkowski & M Baccarini. (2011) Raf kinases in cancer–roles and therapeutic opportunities. Oncogene 30:32, pages 3477-3488.
Crossref
Crossref
Savithri Ramurthy, Mina Aikawa, Payman Amiri, Abran Costales, Ahmad Hashash, Johanna M. Jansen, Song Lin, Sylvia Ma, Paul A. Renhowe, Cynthia M. Shafer, Sharadha Subramanian, Leonard Sung & Joelle Verhagen. (2011) Design and synthesis of 5,6-fused heterocyclic amides as Raf kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 21:11, pages 3286-3289.
Crossref
Crossref
John L. Foster, Sarah J. Denial, Brenda R. S. Temple & J. Victor Garcia. (2011) Mechanisms of HIV-1 Nef Function and Intracellular Signaling. Journal of Neuroimmune Pharmacology 6:2, pages 230-246.
Crossref
Crossref
Hans-Peter Buchstaller, Lars Burgdorf, Dirk Finsinger, Frank Stieber, Christian Sirrenberg, Christiane Amendt, Matthias Grell, Frank Zenke & Mireille Krier. (2011) Design and synthesis of isoquinolines and benzimidazoles as RAF kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 21:8, pages 2264-2269.
Crossref
Crossref
Eva Chung & Motonari Kondo. (2010) Role of Ras/Raf/MEK/ERK signaling in physiological hematopoiesis and leukemia development. Immunologic Research 49:1-3, pages 248-268.
Crossref
Crossref
Juan J. Bonfiglio, Giuseppina Maccarrone, Christiane Rewerts, Florian Holsboer, Eduardo Arzt, Christoph W. Turck & Susana Silberstein. (2011) Characterization of the B-Raf interactome in mouse hippocampal neuronal cells. Journal of Proteomics 74:2, pages 186-198.
Crossref
Crossref
Jonathan R. Halstead, Nicolai E. Savaskan, Iman van den Bout, Francis Van Horck, Amra Hajdo-Milasinovic, Mireille Snell, Willem-Jan Keune, Jean-Paul ten Klooster, Peter L. Hordijk & Nullin Divecha. (2010)
Rac controls PIP5K localisation and PtdIns(4,5)
P
2 synthesis, which modulates vinculin localisation and neurite dynamics
. Journal of Cell Science 123:20, pages 3535-3546.
Crossref
Crossref
Josette Carnahan, Pedro J. Beltran, Carol Babij, Quynh Le, Mark J. Rose, Steven Vonderfecht, Joseph L. Kim, Adrian L. Smith, Karthik Nagapudi, Martin A. Broome, Manory Fernando, Hue Kha, Brian Belmontes, Robert Radinsky, Richard Kendall & Teresa L. Burgess. (2010) Selective and Potent Raf Inhibitors Paradoxically Stimulate Normal Cell Proliferation and Tumor Growth. Molecular Cancer Therapeutics 9:8, pages 2399-2410.
Crossref
Crossref
Antoine Galmiche & Zakaria Ezzoukhry. (2010) Régulation de la survie cellulaire par les kinases de la famille RAF. médecine/sciences 26:8-9, pages 729-733.
Crossref
Crossref
T. S. Niault & M. Baccarini. (2010) Targets of Raf in tumorigenesis. Carcinogenesis 31:7, pages 1165-1174.
Crossref
Crossref
N R Christoffersen, R Shalgi, L B Frankel, E Leucci, M Lees, M Klausen, Y Pilpel, F C Nielsen, M Oren & A H Lund. (2009) p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death & Differentiation 17:2, pages 236-245.
Crossref
Crossref
Gideon Bollag. 2012. Therapeutic Kinase Inhibitors. Therapeutic Kinase Inhibitors
3
18
.
Giuseppe Palmieri, Mariaelena Capone, Maria Libera Ascierto, Giusy Gentilcore, David F Stroncek, Milena Casula, Maria Cristina Sini, Marco Palla, Nicola Mozzillo & Paolo A Ascierto. (2009) Main roads to melanoma. Journal of Translational Medicine 7:1.
Crossref
Crossref
Gerald Thiel, Myriam Ekici & Oliver G Rössler. (2009) Regulation of cellular proliferation, differentiation and cell death by activated Raf. Cell Communication and Signaling 7:1.
Crossref
Crossref
Natalie G Ahn. (2009) PORE-ing over ERK substrates. Nature Structural & Molecular Biology 16:10, pages 1004-1005.
Crossref
Crossref
Hidetaka Kosako, Nozomi Yamaguchi, Chizuru Aranami, Masato Ushiyama, Shingo Kose, Naoko Imamoto, Hisaaki Taniguchi, Eisuke Nishida & Seisuke Hattori. (2009) Phosphoproteomics reveals new ERK MAP kinase targets and links ERK to nucleoporin-mediated nuclear transport. Nature Structural & Molecular Biology 16:10, pages 1026-1035.
Crossref
Crossref
Peng XieCraig StreuJie Qin, Howard BregmanNicholas PaganoEric MeggersRonen Marmorstein. (2009) The Crystal Structure of BRAF in Complex with an Organoruthenium Inhibitor Reveals a Mechanism for Inhibition of an Active Form of BRAF Kinase. Biochemistry 48:23, pages 5187-5198.
Crossref
Crossref
Savithri Ramurthy, Sharadha Subramanian, Mina Aikawa, Payman Amiri, Abran Costales, Jeff Dove, Susan Fong, Johanna M. Jansen, Barry Levine, Sylvia Ma, Christopher M. McBride, Jonah Michaelian, Teresa Pick, Daniel J. Poon, Sandhya Girish, Cynthia M. Shafer, Darrin Stuart, Leonard Sung & Paul A. Renhowe. (2008) Design and Synthesis of Orally Bioavailable Benzimidazoles as Raf Kinase Inhibitors. Journal of Medicinal Chemistry 51:22, pages 7049-7052.
Crossref
Crossref
Hideko Hayashi, Yoshiki Tsuchiya, Kei Nakayama, Takayuki Satoh & Eisuke Nishida. (2008) Down-regulation of the PI3-kinase/Akt pathway by ERK MAP kinase in growth factor signaling. Genes to Cells 13:9, pages 941-947.
Crossref
Crossref
Miki Ebisuya, Takuya Yamamoto, May Nakajima & Eisuke Nishida. (2008) Ripples from neighbouring transcription. Nature Cell Biology 10:9, pages 1106-1113.
Crossref
Crossref
Catherine Noble, Kathryn Mercer, Jahan Hussain, Linda Carragher, Susan Giblett, Robert Hayward, Cam Patterson, Richard Marais & Catrin A. Pritchard. (2008) CRAF Autophosphorylation of Serine 621 Is Required to Prevent Its Proteasome-Mediated Degradation. Molecular Cell 31:6, pages 862-872.
Crossref
Crossref
Kei Nakayama, Takayuki Satoh, Aiko Igari, Ryoichiro Kageyama & Eisuke Nishida. (2008) FGF induces oscillations of Hes1 expression and Ras/ERK activation. Current Biology 18:8, pages R332-R334.
Crossref
Crossref
Amena M. DeLuca, Archana Srinivas & Rhoda M. Alani. (2008) BRAF kinase in melanoma development and progression. Expert Reviews in Molecular Medicine 10.
Crossref
Crossref
Lawrence E. Goldfinger. (2008) Choose your own path: specificity in Ras GTPase signaling. Molecular BioSystems 4:4, pages 293.
Crossref
Crossref
Ariella B. Hanker, Staeci Morita, Gretchen A. Repasky, Douglas T. Ross, Robert S. Seitz & Channing J. Der. 2008. Small GTPases in Disease, Part B. Small GTPases in Disease, Part B
53
72
.
VICTORIA EMUSS & RICHARD MARAIS. 2008. Cancer Drug Design and Discovery. Cancer Drug Design and Discovery
382
402
.
Carine Blanchard, Melissa K. Mingler, Maria Vicario, J. Pablo Abonia, Yi Ying Wu, Thomas X. Lu, Margaret H. Collins, Philip E. Putnam, Susanne I. Wells & Marc E. Rothenberg. (2007) IL-13 involvement in eosinophilic esophagitis: Transcriptome analysis and reversibility with glucocorticoids. Journal of Allergy and Clinical Immunology 120:6, pages 1292-1300.
Crossref
Crossref
Sean W. Wallace & Aron B. Jaffe. 2005. The Cancer Handbook. The Cancer Handbook.
Biswajit Mukherjee, Tanushree Das, Shampa Ghosh & Subrata Datta. (2007) Changes in the antioxidant defense and hepatic drug metabolizing enzyme and isoenzyme levels, 8-hydroxydeoxyguanosine formation and expressions of c-raf.1 and insulin-like growth factor II genes during the stages of development of hepatocellular carcinoma in rats. European Journal of Cancer Prevention 16:4, pages 363-371.
Crossref
Crossref
Mitsuyo Machida, Hidetaka Kosako, Kyoko Shirakabe, Michimoto Kobayashi, Masato Ushiyama, Junichi Inagawa, Joe Hirano, Tomoyo Nakano, Yasuhiko Bando, Eisuke Nishida & Seisuke Hattori. (2007) Purification of phosphoproteins by immobilized metal affinity chromatography and its application to phosphoproteome analysis. FEBS Journal 274:6, pages 1576-1587.
Crossref
Crossref
Nathalie Dhomen & Richard Marais. (2007) New insight into BRAF mutations in cancer. Current Opinion in Genetics & Development 17:1, pages 31-39.
Crossref
Crossref
James A. McCubrey, Fred E. Bertrand, Linda S. Steelman, Fumin Chang, David M. Terrian & Richard A. Franklin. 2007. Apoptosis, Cell Signaling, and Human Diseases. Apoptosis, Cell Signaling, and Human Diseases
101
134
.
J Yue, W Xiong & J E FerrellJrJr. (2006) B-Raf and C-Raf are required for Ras-stimulated p42 MAP kinase activation in Xenopus egg extracts. Oncogene 25:23, pages 3307-3315.
Crossref
Crossref
Takuya Yamamoto, Miki Ebisuya, Fumito Ashida, Kazuo Okamoto, Shin Yonehara & Eisuke Nishida. (2006) Continuous ERK Activation Downregulates Antiproliferative Genes throughout G1 Phase to Allow Cell-Cycle Progression. Current Biology 16:12, pages 1171-1182.
Crossref
Crossref
Gergana Galabova-Kovacs, Dana Matzen, Daniela Piazzolla, Katrin Meissl, Tatiana Plyushch, Adele P. Chen, Alcino Silva & Manuela Baccarini. (2006) Essential role of B-Raf in ERK activation during extraembryonic development. Proceedings of the National Academy of Sciences 103:5, pages 1325-1330.
Crossref
Crossref
Atsushi KUMAGAI, Hiroyuki NAMBA, Shu TAKAKURA, Eiko INAMASU, Vladimir A. SAENKO, Akira OHTSURU & Shunichi YAMASHITA. (2006) No Evidence of ARAF, CRAF and MET Mutations in BRAFT1799A Negative Human Papillary Thyroid Carcinoma. Endocrine Journal 53:5, pages 615-620.
Crossref
Crossref
Kian-Huat Lim & Christopher M. Counter. 2006. RAS Family GTPases. RAS Family GTPases
257
272
.
MAGDALENA KARBOWNICZEK & ELIZABETH PETRI HENSKE. (2005) The Role of Tuberin in Cellular Differentiation: Are B-Raf and MAPK Involved?. Annals of the New York Academy of Sciences 1059:1, pages 168-173.
Crossref
Crossref
Marina Konopleva, Yuexi Shi, Linda S. Steelman, John G. Shelton, Mark Munsell, Frank Marini, Teresa McQueen, Rooha Contractor, James A. McCubrey & Michael Andreeff. (2005)
Development of a Conditional
In vivo
Model to Evaluate the Efficacy of Small Molecule Inhibitors for the Treatment of Raf-Transformed Hematopoietic Cells
. Cancer Research 65:21, pages 9962-9970.
Crossref
Crossref
Rana Anjum, Philippe P. Roux, Bryan A. Ballif, Steven P. Gygi & John Blenis. (2005) The Tumor Suppressor DAP Kinase Is a Target of RSK-Mediated Survival Signaling. Current Biology 15:19, pages 1762-1767.
Crossref
Crossref
Muralidhar Beeram, Amita Patnaik & Eric K. Rowinsky. (2005) Raf: A Strategic Target for Therapeutic Development Against Cancer. Journal of Clinical Oncology 23:27, pages 6771-6790.
Crossref
Crossref
Claus Christensen & Per Guldberg. (2005) Growth factors rescue cutaneous melanoma cells from apoptosis induced by knockdown of mutated (V600E) B-RAF. Oncogene 24:41, pages 6292-6302.
Crossref
Crossref
Eleonora Olivetta, Donatella Pietraforte, Ilaria Schiavoni, Maurizio Minetti, Maurizio Federico & Massimo Sanchez. (2005) HIV-1 Nef regulates the release of superoxide anions from human macrophages. Biochemical Journal 390:2, pages 591-602.
Crossref
Crossref
Kathryn Mercer, Susan Giblett, Anthony Oakden, Jane Brown, Richard Marais & Catrin Pritchard. (2005) A-Raf and Raf-1 work together to influence transient ERK phosphorylation and Gl/S cell cycle progression. Oncogene 24:33, pages 5207-5217.
Crossref
Crossref
Tamihiro KamataJing KangTzong-Hae LeeLeszek WojnowskiCatrin A. PritchardAndrew D. Leavitt. (2005) A critical function for B-Raf at multiple stages of myelopoiesis. Blood 106:3, pages 833-840.
Crossref
Crossref
Elizabeth S. Mahon, Andrea D. Hawrysh, Ryaz B. Chagpar, Lindsey M. Johnson & Deborah H. Anderson. (2005) A-Raf associates with and regulates platelet-derived growth factor receptor signalling. Cellular Signalling 17:7, pages 857-868.
Crossref
Crossref
Manuela Baccarini. (2005) Second nature: Biological functions of the Raf-1 “kinase”. FEBS Letters 579:15, pages 3271-3277.
Crossref
Crossref
Mohamed Rahmani, Erin Reese, Yun Dai, Cheryl Bauer, Lora B. Kramer, Mei Huang, Richard Jove, Paul Dent & Steven Grant. (2005)
Cotreatment with Suberanoylanilide Hydroxamic Acid and 17-Allylamino 17-demethoxygeldanamycin Synergistically Induces Apoptosis in Bcr-Abl
+
Cells Sensitive and Resistant to STI571 (Imatinib Mesylate) in Association with Down-Regulation of Bcr-Abl, Abrogation of Signal Transducer and Activator of Transcription 5 Activity, and Bax Conformational Change
. Molecular Pharmacology 67:4, pages 1166-1176.
Crossref
Crossref
Nancy H. Tran, Xiaochong Wu & Jeffrey A. Frost. (2005) B-Raf and Raf-1 Are Regulated by Distinct Autoregulatory Mechanisms. Journal of Biological Chemistry 280:16, pages 16244-16253.
Crossref
Crossref
Tony Pawson & Rune Linding. (2005) Synthetic modular systems - reverse engineering of signal transduction. FEBS Letters 579:8, pages 1808-1814.
Crossref
Crossref
Karin Ehrenreiter, Daniela Piazzolla, Vanishree Velamoor, Izabela Sobczak, J. Victor Small, Junji Takeda, Thomas Leung & Manuela Baccarini. (2005) Raf-1 regulates Rho signaling and cell migration. Journal of Cell Biology 168:6, pages 955-964.
Crossref
Crossref
Anthony Ambesi, R. Matthew Klein, Kevin M. Pumiglia & Paula J. McKeown-Longo. (2005) Anastellin, a Fragment of the First Type III Repeat of Fibronectin, Inhibits Extracellular Signal-Regulated Kinase and Causes G1 Arrest in Human Microvessel Endothelial Cells. Cancer Research 65:1, pages 148-156.
Crossref
Crossref
Paul Dent. 2005. Signaling Pathways in Liver Diseases. Signaling Pathways in Liver Diseases
223
238
.
Claudia Wellbrock, Maria Karasarides & Richard Marais. (2004) The RAF proteins take centre stage. Nature Reviews Molecular Cell Biology 5:11, pages 875-885.
Crossref
Crossref
Weicheng Liu, Xiaoyun Shen, Yanzhong Yang, Xianglei Yin, Jianhui Xie, Jun Yan, Jianhai Jiang, Wenjin Liu, Hanzhou Wang, Maoyun Sun, Ying Zheng & Jianxin Gu. (2004) Trihydrophobin 1 Is a New Negative Regulator of A-Raf Kinase. Journal of Biological Chemistry 279:11, pages 10167-10175.
Crossref
Crossref
Ulf R Rapp, Ulrike Rennefahrt & Jakob Troppmair. (2004) Bcl-2 proteins: master switches at the intersection of death signaling and the survival control by Raf kinases. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1644:2-3, pages 149-158.
Crossref
Crossref
L S Steelman, S C Pohnert, J G Shelton, R A Franklin, F E Bertrand & J A McCubrey. (2004) JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 18:2, pages 189-218.
Crossref
Crossref
Armelle Calipel, Gaelle Lefevre, Celio Pouponnot, Frédéric Mouriaux, Alain Eychène & Frédéric Mascarelli. (2003) Mutation of B-Raf in Human Choroidal Melanoma Cells Mediates Cell Proliferation and Transformation through the MEK/ERK Pathway. Journal of Biological Chemistry 278:43, pages 42409-42418.
Crossref
Crossref
M K White. (2003) Small-molecule inhibitors of signal transduction pathways in leukemia therapeutics: how to assess selectivity for malignant signals. Leukemia 17:9, pages 1759-1761.
Crossref
Crossref
J G Shelton, P W Moye, L S Steelman, W L Blalock, J T Lee, R A Franklin, M McMahon & J A McCubrey. (2003) Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferation. Leukemia 17:9, pages 1765-1782.
Crossref
Crossref
F Chang, L S Steelman, J T Lee, J G Shelton, P M Navolanic, W L Blalock, R A Franklin & J A McCubrey. (2003) Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia 17:7, pages 1263-1293.
Crossref
Crossref
Kathryn E. Mercer & Catrin A. Pritchard. (2003) Raf proteins and cancer: B-Raf is identified as a mutational target. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1653:1, pages 25-40.
Crossref
Crossref
Huira Chong, Haris G Vikis & Kun-Liang Guan. (2003) Mechanisms of regulating the Raf kinase family. Cellular Signalling 15:5, pages 463-469.
Crossref
Crossref
Momoko Maekawa, Eisuke Nishida & Takuji Tanoue. (2002) Identification of the Anti-proliferative Protein Tob as a MAPK Substrate. Journal of Biological Chemistry 277:40, pages 37783-37787.
Crossref
Crossref
Edward Im, Friederike C von Lintig, Jeffrey Chen, Shunhui Zhuang, Wansong Qui, Shoaib Chowdhury, Paul F Worley, Gerry R Boss & Renate B Pilz. (2002) Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells. Oncogene 21:41, pages 6356-6365.
Crossref
Crossref
Elzbieta Janda, Gabi Litos, Stefan Grünert, Julian Downward & Hartmut Beug. (2002) Oncogenic Ras/Her-2 mediate hyperproliferation of polarized epithelial cells in 3D cultures and rapid tumor growth via the PI3K pathway. Oncogene 21:33, pages 5148-5159.
Crossref
Crossref
M Baccarini. (2002) An old kinase on a new path: Raf and apoptosis. Cell Death & Differentiation 9:8, pages 783-785.
Crossref
Crossref
Leon O. Murphy, Sallie Smith, Rey-Huei Chen, Diane C. Fingar & John Blenis. (2002) Molecular interpretation of ERK signal duration by immediate early gene products. Nature Cell Biology 4:8, pages 556-564.
Crossref
Crossref
Kathryn Mercer, Antonio Chiloeches, Martin Hüser, Michelle Kiernan, Richard Marais & Catrin Pritchard. (2002) ERK signalling and oncogene transformation are not impaired in cells lacking A-Raf. Oncogene 21:3, pages 347-355.
Crossref
Crossref
Yutaka Matsubayashi, Makoto Fukuda & Eisuke Nishida. (2001) Evidence for Existence of a Nuclear Pore Complex-mediated, Cytosol-independent Pathway of Nuclear Translocation of ERK MAP Kinase in Permeabilized Cells. Journal of Biological Chemistry 276:45, pages 41755-41760.
Crossref
Crossref
Andrew S. Greenberg, Wen-Jun Shen, Kizito Muliro, Shailja Patel, Sandra C. Souza, Richard A. Roth & Fredric B. Kraemer. (2001) Stimulation of Lipolysis and Hormone-sensitive Lipase via the Extracellular Signal-regulated Kinase Pathway. Journal of Biological Chemistry 276:48, pages 45456-45461.
Crossref
Crossref
Victor Y Stefanovsky, Guillaume Pelletier, Ross Hannan, Thérèse Gagnon-Kugler, Lawrence I Rothblum & Tom Moss. (2001) An Immediate Response of Ribosomal Transcription to Growth Factor Stimulation in Mammals Is Mediated by ERK Phosphorylation of UBF. Molecular Cell 8:5, pages 1063-1073.
Crossref
Crossref
Monica S. MurakamiDeborah K. Morrison. (2001) Raf-1 Without MEK?. Science's STKE 2001:99.
Crossref
Crossref
Fumin Chang & James A McCubrey. (2001) P21Cip1 induced by Raf is associated with increased Cdk4 activity in hematopoietic cells. Oncogene 20:32, pages 4354-4364.
Crossref
Crossref
WL Blalock, M Pearce, F Chang, JT Lee, SC Pohnert, C Burrows, LS Steelman, RA Franklin, M McMahon & JA McCubrey. (2001) Effects of inducible MEK1 activation on the cytokine dependency of lymphoid cells. Leukemia 15:5, pages 794-807.
Crossref
Crossref
James A McCubrey, Linda S Steelman, William L Blalock, John T Lee, Phillip W Moye, Fumin Chang, Marianne Pearce, John G Shelton, Martyn K White, Richard A Franklin & Steven C Pohnert. (2001) Synergistic effects of pi3k/akt on abrogation of cytokine-dependency induced by oncogenic raf. Advances in Enzyme Regulation 41:1, pages 289-323.
Crossref
Crossref
James D. Richards, Shaival H. Davé, Chih-Hao G. Chou, Alusha A. Mamchak & Anthony L. DeFranco. (2001) Inhibition of the MEK/ERK Signaling Pathway Blocks a Subset of B Cell Responses to Antigen. The Journal of Immunology 166:6, pages 3855-3864.
Crossref
Crossref
Hiroshi Mizuno & Eisuke Nishida. (2001) The ERK MAP kinase pathway mediates induction of SGK (serum- and glucocorticoid-inducible kinase) by growth factors. Genes to Cells 6:3, pages 261-268.
Crossref
Crossref
Scott F. Walk, Melissa Alexander, Bernhard Maier, Marie-Louise Hammarskjold, David M. Rekosh & Kodi S. Ravichandran. (2001) Design and Use of an Inducibly Activated Human Immunodeficiency Virus Type 1 Nef To Study Immune Modulation. Journal of Virology 75:2, pages 834-843.
Crossref
Crossref
Martin McMahon. 2001. Part F: Regulators and Effectors of Small GTPases. Part F: Regulators and Effectors of Small GTPases
401
417
.
Caroline R Weinstein-Oppenheimer, William L Blalock, Linda S Steelman, Fumin Chang & James A McCubrey. (2000) The Raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor-responsive tumors. Pharmacology & Therapeutics 88:3, pages 229-279.
Crossref
Crossref
C Weinstein-Oppenheimer, LS Steelman, PA Algate, WL Blalock, C Burrows, PE Hoyle, JT Lee, PW Moye, JG Shelton, R Franklin & JA McCubrey. (2000) Effects of deregulated Raf activation on integrin, cytokine-receptor expression and the induction of apoptosis in hematopoietic cells. Leukemia 14:11, pages 1921-1938.
Crossref
Crossref
Wansong Qiu, Shunhui Zhuang, Friederike C. von Lintig, Gerry R. Boss & Renate B. Pilz. (2000) Cell Type-specific Regulation of B-Raf Kinase by cAMP and 14-3-3 Proteins. Journal of Biological Chemistry 275:41, pages 31921-31929.
Crossref
Crossref
Albrecht Piiper, Ralph Gebhardt, Bernd Kronenberger, Claudio D. Giannini, Robert Elez & Stefan Zeuzem. (2000) Pertussis Toxin Inhibits Cholecystokinin- and Epidermal Growth Factor-Induced Mitogen-Activated Protein Kinase Activation by Disinhibition of the cAMP Signaling Pathway and Inhibition of c-Raf-1. Molecular Pharmacology 58:3, pages 608-613.
Crossref
Crossref
Chad A Ellis & Geoff Clark. (2000) The importance of being K-Ras. Cellular Signalling 12:7, pages 425-434.
Crossref
Crossref
WL Blalock, PW Moye, F Chang, M Pearce, LS Steelman, M McMahon & JA McCubrey. (2000) Combined effects of aberrant MEK1 activity and BCL2 overexpression on relieving the cytokine dependency of human and murine hematopoietic cells. Leukemia 14:6, pages 1080-1096.
Crossref
Crossref
PW Moye, WL Blalock, PE Hoyle, F Chang, RA Franklin, C Weinstein-Oppenheimer, M Pearce, L Steelman, M McMahon & JA McCubrey. (2000) Synergy between Raf and BCL2 in abrogating the cytokine dependency of hematopoietic cells. Leukemia 14:6, pages 1060-1079.
Crossref
Crossref
James A McCubrey, Linda S Steelman, Phillip W Moye, Paul E Hoyle, Caroline Weinstein-Oppenheimer, Fumin Chang, Marianne Pearce, Martyn K White, Richard Franklin & William L Blalock. (2000) Effects of deregulated RAF and MEK1 expression on the cytokine-dependency of hematopoietic cells. Advances in Enzyme Regulation 40:1, pages 305-337.
Crossref
Crossref
PE Hoyle, PW Moye, LS Steelman, WL Blalock, RA Franklin, M Pearce, H Cherwinski, E Bosch, M McMahon & JA McCubrey. (2000) Differential abilities of the Raf family of protein kinases to abrogate cytokine dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism. Leukemia 14:4, pages 642-656.
Crossref
Crossref
Makoto Akashi & Eisuke Nishida. (2000) Involvement of the MAP kinase cascade in resetting of the mammalian circadian clock. Genes & Development 14:6, pages 645-649.
Crossref
Crossref
Makoto Adachi, Makoto Fukuda & Eisuke Nishida. (2000) Nuclear Export of Map Kinase (ERK) Involves a Map Kinase Kinase (Mek-Dependent) Active Transport Mechanism. Journal of Cell Biology 148:5, pages 849-856.
Crossref
Crossref
Leszek Wojnowski, Louis F Stancato, Andrew C Larner, Ulf R Rapp & Andreas Zimmer. (2000) Overlapping and specific functions of Braf and Craf-1 proto-oncogenes during mouse embryogenesis. Mechanisms of Development 91:1-2, pages 97-104.
Crossref
Crossref
Melanie C. MacNicol, Anthony J. Muslin & Angus M. MacNicol. (2000) Disruption of the 14-3-3 Binding Site within the B-Raf Kinase Domain Uncouples Catalytic Activity from PC12 Cell Differentiation. Journal of Biological Chemistry 275:6, pages 3803-3809.
Crossref
Crossref
Takuji Tanoue, Makoto Adachi, Tetsuo Moriguchi & Eisuke Nishida. (2000) A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nature Cell Biology 2:2, pages 110-116.
Crossref
Crossref
William L Blalock, Marianne Pearce, Linda S Steelman, Richard A Franklin, Sean A McCarthy, Holly Cherwinski, Martin McMahon & James A McCubrey. (2000) A conditionally-active form of MEK1 results in autocrine transformation of human and mouse hematopoietic cells. Oncogene 19:4, pages 526-536.
Crossref
Crossref
JA McCubrey, W Stratford May, V Duronio & A Mufson. (2000) Serine/threonine phosphorylation in cytokine signal transduction. Leukemia 14:1, pages 9-21.
Crossref
Crossref
Didier Picard. 2000. Applications of Chimeric Genes and Hybrid Proteins - Part B: Cell Biology and Physiology. Applications of Chimeric Genes and Hybrid Proteins - Part B: Cell Biology and Physiology
385
401
.
Hirokazu Kurata, Hyun Jun Lee, Anne O'Garra & Naoko Arai. (1999) Ectopic Expression of Activated Stat6 Induces the Expression of Th2-Specific Cytokines and Transcription Factors in Developing Th1 Cells. Immunity 11:6, pages 677-688.
Crossref
Crossref
Carsten Hagemann & Ulf R. Rapp. (1999) Isotype-Specific Functions of Raf Kinases. Experimental Cell Research 253:1, pages 34-46.
Crossref
Crossref
Megan K. LevingsDarrell C. BessetteJohn W. Schrader. (1999) Interleukin-4 Synergizes With Raf-1 to Promote Long-Term Proliferation and Activation of c-jun N-terminal Kinase. Blood 93:11, pages 3694-3702.
Crossref
Crossref
Megan K. LevingsDarrell C. BessetteJohn W. Schrader. (1999) Interleukin-4 Synergizes With Raf-1 to Promote Long-Term Proliferation and Activation of c-jun N-terminal Kinase. Blood 93:11, pages 3694-3702.
Crossref
Crossref
Melanie C. MacNicol & Angus M. MacNicol. (1999) Nerve Growth Factor-stimulated B-Raf Catalytic Activity Is Refractory to Inhibition by cAMP-dependent Protein Kinase. Journal of Biological Chemistry 274:19, pages 13193-13197.
Crossref
Crossref
Catherine Papin, Anne Denouel-Galy, Danielle Laugier, Georges Calothy & Alain Eychène. (1998) Modulation of Kinase Activity and Oncogenic Properties by Alternative Splicing Reveals a Novel Regulatory Mechanism for B-Raf. Journal of Biological Chemistry 273:38, pages 24939-24947.
Crossref
Crossref
Yumiko Kamogawa, Hyun Jun Lee, James A. Johnston, Martin McMahon, Anne O’Garra & Naoko Arai. (1998) Cutting Edge: A Conditionally Active Form of STAT6 Can Mimic Certain Effects of IL-4. The Journal of Immunology 161:3, pages 1074-1077.
Crossref
Crossref
Leszek Wojnowski, Louis F Stancato, Anne M Zimmer, Heidi Hahn, Thomas W Beck, Andrew C Larner, Ulf R. Rapp & Andreas Zimmer. (1998) Craf-1 protein kinase is essential for mouse development. Mechanisms of Development 76:1-2, pages 141-149.
Crossref
Crossref
Stephen M Prouty, Anjli Maroo, Cora Maucher, Harald Mischak, Walter Kolch & John M Sedivy. (1998) Studies of perinuclear and nuclear translocation of the Raf-1 protein in rodent fibroblasts. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1402:1, pages 6-16.
Crossref
Crossref
Timothy S. Lewis, Paul S. Shapiro & Natalie G. Ahn. 1998.
49
139
.
J. R. Slupsky, C. K. Weber, S. Ludwig & U. R. Rapp. 1997. Cell Growth and Oncogenesis. Cell Growth and Oncogenesis
75
95
.
Kathryn De Fea & Richard A. Roth. (1997) Modulation of Insulin Receptor Substrate-1 Tyrosine Phosphorylation and Function by Mitogen-activated Protein Kinase. Journal of Biological Chemistry 272:50, pages 31400-31406.
Crossref
Crossref
Andrzej Dabrowski, Guy E. Groblewski, Claus Schäfer, Kun-Liang Guan & John A. Williams. (1997) Cholecystokinin and EGF activate a MAPK cascade by different mechanisms in rat pancreatic acinar cells. American Journal of Physiology-Cell Physiology 273:5, pages C1472-C1479.
Crossref
Crossref
Peter H Sugden & Angela Clerk. (1997) Regulation of the ERK Subgroup of MAP Kinase Cascades Through G Protein-Coupled Receptors. Cellular Signalling 9:5, pages 337-351.
Crossref
Crossref
Leszek Wojnowski, Anne M. Zimmer, Thomas W. Beck, Heidi Hahn, Ricardo Bernal, Ulf R. Rapp & Andreas Zimmer. (1997) Endothelial apoptosis in Braf-deficient mice. Nature Genetics 16:3, pages 293-297.
Crossref
Crossref
Catrin Pritchard & Martin McMahon. (1997) Raf revealed in life-or-death decisions. Nature Genetics 16:3, pages 214-215.
Crossref
Crossref
Herbert Schramek, Elisabeth Feifel, Edel Healy & Verena Pollack. (1997) Constitutively Active Mutant of the Mitogen-activated Protein Kinase Kinase MEK1 Induces Epithelial Dedifferentiation and Growth Inhibition in Madin-Darby Canine Kidney-C7 Cells. Journal of Biological Chemistry 272:17, pages 11426-11433.
Crossref
Crossref
Richard Marais, Yvonne Light, Hugh F. Paterson, Clive S. Mason & Christopher J. Marshall. (1997) Differential Regulation of Raf-1, A-Raf, and B-Raf by Oncogenic Ras and Tyrosine Kinases. Journal of Biological Chemistry 272:7, pages 4378-4383.
Crossref
Crossref
Kevin M. Pumiglia & Stuart J. Decker. (1997) Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proceedings of the National Academy of Sciences 94:2, pages 448-452.
Crossref
Crossref
Robin Hesketh. 1997. The Oncogene & Tumour Suppressor Gene Factsbook. The Oncogene & Tumour Suppressor Gene Factsbook
309
318
.
M. Jorge Guimarães, David Peterson, Alain Vicari, Benjamin G. Cocks, Neal G. Copeland, Debra J. Gilbert, Nancy A. Jenkins, David A. Ferrick, Robert A. Kastelein, J. Fernando Bazan & Albert Zlotnik. (1996)
Identification of a novel
selD
homolog from Eukaryotes, Bacteria, and Archaea: Is there an autoregulatory mechanism in selenocysteine metabolism?
. Proceedings of the National Academy of Sciences 93:26, pages 15086-15091.
Crossref
Crossref
Viktor Wixler, Ute Smola, Manuela Schuler & Ulf Rapp. (1996) Differential regulation of Raf isozymes by growth versus differentiation inducing factors in PC12 pheochromocytoma cells. FEBS Letters 385:3, pages 131-137.
Crossref
Crossref
C.A Pritchard, L Bolin, R Slattery, R Murray & M McMahon. (1996) Post-natal lethality and neurological and gastrointestinal defects in mice with targeted disruption of the A-Raf protein kinase gene. Current Biology 6:5, pages 614-617.
Crossref
Crossref